Trailing Twelve Months Revenue Growth: NLS Pharmaceutics AG (NLSP)

Graphic logo of NLS Pharmaceutics (NLSP)

Can NLS Pharmaceutics AG (NLSP) meet the high demand for narcolepsy treatment? NLS Pharmaceutics AG (NLSP) is integrating ESG principles and bioethics into the development of insomnia treatments, as evidenced by the year-over-year sales trend over the last 12 months on the GURU.Markets chart, where the latest value is recorded as 0.00. This is further supported by the diversification of research and development in the fields of ADHD and cognitive disorders.

NLS Pharmaceutics (NLSP): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 02/20/2024

Summary analytical data breakdowns for NLS Pharma (NLSP)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Analysis of all company metrics:NLSP NLS Pharmaceutics Ltd.
Flagship merchandise of NLS Pharmaceutics Ltd.

This indicator captures the percentage change in revenue over the last 12 months relative to the preceding year, allowing for an assessment of the actual cash flow stability. By analyzing the year-over-year commercial revenue dynamics over a rolling year, an investor can determine the effectiveness of the current NLS Pharmaceutics AG (NLSP) strategy to expand its neuro-drug portfolio through potential M&A transactions or the integration of new technological teams.